Global
Excipients for Drug Formulation

Ludipress® LCE

Ludipress® LCE is a ready-to-use direct compression solution for lozenges, chewables and effervescent tablet. The white, free-flowin granulate that means quicker, easier, and more cost-effective tableting. With Ludipress® LCE, you save precious time on developing, analyzing and blending. You simply add your active ingredient, a lubricant, and compress your tablets. It is that easy.

Ludipress® LCE means less effort, lower costs, and higher quality for lozenges, chewables, sublingual or effervescent tablets and modified release formulations. Ludipress® LCE does – in contrast to Ludipress® – not contain the disintegrant Kollidon® CL. Ludipress® LCE is therefore completely water-soluble and particularly suitable for the cost saving direct compression of processing. It enables direct compression of the majority of tablets that do not require a disintegrant. Like Ludipress®, Ludipress® LCE is a granulate that forms a homogenous mixture with the active ingredient – saving you development and analysis costs, and enabling you to quickly achieve the perfect formulation. When disintegrant Kollidon® CL is admixed, Ludipress® LCE is also suitable for all other kinds of tablets. When combined with an additional dry binder in the shape of Kollidon® VA 64, Ludipress® LCE can also be employed for high-dosage formulations.

Ludipress® LCE – enabling efficient direct tablet manufacturing

  • Streamlines the production process, reducing complexity and effort like no other direct-tableting excipient
  • Completely water-soluble
  • Outstanding binding power
  • Excellent flowability and ideal particle size distribution
  • Produces tablets of exceptional hardness
  • Accelerates product development
Ludipress® LCE
Product Details
Chemical name Lactose, povidone
CAS-No. 5989-81-1 + 9003-39-8
Regulatory Status The formulated ingredients lactose monohydrate and Kollidon® 30 correspond to the current monographs in Ph. Eur., USP/NF and J.P.
Applications The main application is for direct compression for use in chewable tablets and lozenges, for effervescent tablets and as bulking agent for modified release formulations.
Ludipress® LCE composition

96.5% Lactose + 3.5% Kollidon® 30

The result: a granulate comprising carrier and filler as well as a tried and tested Povidone binder, with superior binding power.

How direct compression with Ludipress® saves you time and money.

Learn more about Ludipress® LCE

Portfolio Overview

Focusing on your needs with platform solutions

Download Center

Looking for application guides, technical and scientific posters, brochures or technical information? Visit our Download Center.

Related Process Technologies

Related Solution Platforms